Becton Dickinson & Co. closed 32.13% below its 52-week high of $251.99, which the company reached on February 3rd.

Becton, Dickinson and Company ( NYSE: BDX) Bank of America Securities Health Care Conference Call May 13, 2025 1:00 PM ET Tom Polen - Chairman, Chief Executive Officer and President ...

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

Even though Becton, Dickinson and Company (NYSE:BDX) posted strong earnings, investors appeared to be underwhelmed. We have done some analysis and have found some comforting factors beneath the ...

Over 300 people are undergoing a precautionary “decontamination” process after a suspicious package incident at the Becton ...

Multiple state and federal agencies, including the FBI, responded to Grace Way after a suspicious package was found, leading to hundreds of employees of a local business needing to undergo ...

Tuesday  announced the global commercial launch of the world's first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies.

Shares of Becton Dickinson & Co. BDX advanced 4.86% to $175.34 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 3.26% to ...

"Jeff is a visionary leader with a strong track record of driving global success in the life sciences and medical device industries," said Jay Katzen, Executive Chairman, Fotona. "We are excited to ...

The most notable increase was in Becton Dickinson & Co (NYSE:BDX), with an additional 1,091,690 shares, bringing the total to 5,517,712 shares. This adjustment represents a significant 24.67% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...